Based on the clinical data, we showed that OSA patients had decreased LC3B expression than PS subjects in association with hypermethylation of the LC3B gene promoter regions, while both markers were correlated with AHI. Here, MAP1LC3B is linked to obstructive sleep apnea syndrome.